{"id":"W4213002005","doi":"10.2340/actadv.v102.1984","title":"Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis","year":2022,"lang":"en","type":"article","venue":"Acta Dermato Venereologica","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Confidence interval; Psoriasis; Placebo; Post-hoc analysis; Randomized controlled trial; Clinical trial; Internal medicine; Psoriasis Area and Severity Index; Dermatology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004113518,0.0002583074,0.0009663206,0.0003137361,0.0002645996,0.0007263346,0.0002530456,0.0004739062,0.00137122],"category_scores_gemma":[0.005580944,0.0001506672,0.001376742,0.0003282142,0.0002319576,0.0005169405,0.0002779856,0.001171408,0.0002023882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004604604,"about_ca_system_score_gemma":0.00062551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004326309,"about_ca_topic_score_gemma":0.0006357582,"domain_scores_codex":[0.9979874,0.001185487,0.0001529006,0.0002118576,0.0002691812,0.0001931564],"domain_scores_gemma":[0.9948555,0.002702759,0.001539479,0.000262658,0.0001905144,0.0004490326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3140337,0.003657441,0.4712217,0.0008371063,0.002421811,0.0007757118,0.0004501188,0.002617371,0.01539821,0.0002797917,0.001670888,0.1866361],"study_design_scores_gemma":[0.009972039,0.1368043,0.8370862,0.000106421,0.001442635,0.001575536,0.000284865,0.004456768,0.004138661,0.0007098186,0.003361483,0.00006122325],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99538,0.002868161,0.0005264294,0.0001604264,0.00002476723,0.00009663814,0.0002081663,0.00001786866,0.0007174192],"genre_scores_gemma":[0.9991528,0.0002476854,0.0001173833,0.00007558208,0.00002282049,0.00003175577,0.0001531027,0.000002930252,0.0001959573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004113518,"threshold_uncertainty_score":0.02175468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007000644510678062,"score_gpt":0.2045205424398759,"score_spread":0.1975198979291979,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}